Owners, management and financials
CVR: 41192925
DKK -247,887
Gross profit
Net result: DKK -859,076
MEDIC ADVICE ApS (5-9,99%), MR Jakobsen Holding ApS (15-19,99%)
3 more
CVR · view owners
Martin Roelsgaard Jakobsen
Board: Ulrik Bjerl Nielsen (chair) and 2 members
CVR · view management
Active
Founded 17 February 2020
CVR · view overview
2 employees
CVR · 2025
Director registered: Martin Roelsgaard Jakobsen
CVR · 01/10/2024
View the full event history
UNIKUM Therapeutics ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Roelsgaard Jakobsen. The board consists of Ulrik Bjerl Nielsen (chair), Martin Roelsgaard Jakobsen and Stefan Wildt. The company's owners include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -248 t. | -859 t. | 138 t. | -5.7 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | -7.4 mio. | -13.8 mio. | 3.8 mio. | -4.8 mio. | 9 | |
| 202301/01/2023 – 31/12/2023 | -7.5 mio. | -14.9 mio. | 4 mio. | -16.3 mio. | 9 | |
| 202201/01/2022 – 31/12/2022 | -3.3 mio. | -7.6 mio. | 3.1 mio. | -15.3 mio. | 7 | |
| 202101/01/2021 – 31/12/2021 | -2.7 mio. | -5.6 mio. | 6.7 mio. | -7.6 mio. | 5 | |
| 202017/02/2020 – 31/12/2020 | -1.1 mio. | -2.1 mio. | 2.3 mio. | -2.1 mio. | 2 |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of UNIKUM Therapeutics ApS is 41192925.
The owners of UNIKUM Therapeutics ApS include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S.
The management of UNIKUM Therapeutics ApS consists of Martin Roelsgaard Jakobsen.
The board of UNIKUM Therapeutics ApS consists of Ulrik Bjerl Nielsen, Martin Roelsgaard Jakobsen and Stefan Wildt, with Ulrik Bjerl Nielsen as chair.
In 2025, UNIKUM Therapeutics ApS reported a gross profit of DKK -247,887.
UNIKUM Therapeutics ApS had 2 employees in 2025 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
UNIKUM Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -247,887, and the net result was DKK -859,076.
UNIKUM Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -7,368,177, and the net result was DKK -13,797,011.
As of May 27, 2025, Nebojsa Milovic has left the board of directors of UNIKUM Therapeutics ApS.
As of May 27, 2025, Margo Rosemary Roberts has left the board of directors of UNIKUM Therapeutics ApS.
As of October 1, 2024, Martin Roelsgaard Jakobsen is registered as director of UNIKUM Therapeutics ApS.
As of September 30, 2024, Tommi Petteri Kainu has stepped down as director of UNIKUM Therapeutics ApS.
As of August 12, 2024, Stefan Wildt has joined the board of directors of UNIKUM Therapeutics ApS.
As of August 12, 2024, Johannes Heinrich Frühauf has left the board of directors of UNIKUM Therapeutics ApS.
As of June 14, 2024, MR Jakobsen Holding ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 15%.
UNIKUM Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -7,465,410, and the net result was DKK -14,870,759.
As of March 20, 2024, BII Holdings A/S is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.
As of February 5, 2024, is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 33%.
As of October 4, 2023, MEDIC ADVICE ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.
As of October 4, 2023, RO Bak Holding ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.
As of September 30, 2023, Rasmus Otkjær Bak has stepped down as adm. dir. of UNIKUM Therapeutics ApS.
As of August 1, 2023, Margo Rosemary Roberts has joined the board of directors of UNIKUM Therapeutics ApS.
UNIKUM Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -3,315,358, and the net result was DKK -7,648,614.
As of April 18, 2023, Rasmus Otkjær Bak is registered as adm. dir. of UNIKUM Therapeutics ApS.
As of April 18, 2023, Tommi Petteri Kainu is registered as director of UNIKUM Therapeutics ApS.
As of April 17, 2023, Rasmus Otkjær Bak has stepped down as director of UNIKUM Therapeutics ApS.
As of March 2, 2023, Johannes Heinrich Frühauf has joined the board of directors of UNIKUM Therapeutics ApS.
As of March 2, 2023, Nebojsa Milovic has joined the board of directors of UNIKUM Therapeutics ApS.
UNIKUM Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK -2,726,200, and the net result was DKK -5,555,369.
UNIKUM Therapeutics ApS has published its interim report for the period February 17, 2020 – December 31, 2020.
As of April 1, 2021, Rasmus Otkjær Bak is registered as director of UNIKUM Therapeutics ApS.
As of April 1, 2021, Søren Sylvester Skjærbæk has stepped down as director of UNIKUM Therapeutics ApS.
As of February 17, 2020, Martin Roelsgaard Jakobsen has joined the board of directors of UNIKUM Therapeutics ApS.
As of February 17, 2020, Ulrik Bjerl Nielsen has joined the board of directors of UNIKUM Therapeutics ApS.
As of February 17, 2020, Søren Sylvester Skjærbæk is registered as director of UNIKUM Therapeutics ApS.
UNIKUM Therapeutics ApS was founded on February 17, 2020.
Companies in the same industry and area
CVR 46260643
CVR 37416932
CVR 46274199
CVR 10403782
CVR 31576393
